Mark Perrin

2016

In 2016, Mark Perrin earned a total compensation of $741.9K as Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings, a 61% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$111,263
Salary$445,050
Other$185,623
Total$741,936

Perrin received $445.1K in salary, accounting for 60% of the total pay in 2016.

Perrin also received $111.3K in non-equity incentive plan and $185.6K in other compensation.

Rankings

In 2016, Mark Perrin's compensation ranked 9,629th out of 14,075 executives tracked by ExecPay. In other words, Perrin earned more than 31.6% of executives.

ClassificationRankingPercentile
All
9,629
out of 14,075
32nd
Division
Manufacturing
3,730
out of 5,489
32nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
490
out of 827
41st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
283
out of 510
45th
Industry
Surgical and Medical Instruments and Apparatus
168
out of 313
46th
Source: SEC filing on April 25, 2017.

Perrin's colleagues

We found six more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2016.

2016

Pamela Stahl

InVivo Therapeutics Holdings

Chief Commercial Officer

2016

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2016

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2016

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2016

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

2016

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

You may also like